Jain Global’s Avadel Pharmaceuticals AVDL Stock Holding History

Jain Global’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,976	Closed	-$301K	–	1214
2025 Q4	$301K	Buy	+13,976	New	+$271K	﹤0.01%	956
2025 Q3	–	Sell	-26,314	Closed	-$233K	–	1028
2025 Q2	$233K	Buy	+26,314	New	+$231K	﹤0.01%	943

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Jain Global's AVDL Position: Q1 2026 in Review

Jain Global sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 13,976 shares — an estimated $301K sold.

Jain Global first reported a position in AVDL in Q2 2025 and held it in 2 quarters. The position peaked at $301K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Jain Global reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Jain Global sold 13,976 Avadel Pharmaceuticals shares in Q1 2026, an estimated $301K.
Jain Global first reported a position in Avadel Pharmaceuticals in Q2 2025 and held it in 2 quarters.
Jain Global's Avadel Pharmaceuticals position peaked at $301K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.